EMIT II Plus Phencyclidine AssayScreen for PCP at a cutoff of 25 ng/mL

The EMIT® II Plus Phencyclidine Assay is intended for the qualitative and semiquantitative analysis of phencyclidine in human urine at a cutoff value of 25 ng/mL. The SAMHSA initial test cutoff level is 25 ng/mL.

Contact Us

Features & Benefits

Phencyclidine, also known as PCP and “angel dust,” is a synthetic drug that was originally developed for its anesthetic properties but is now a drug of abuse used solely for its potent hallucinogenic effects. Phencyclidine is absorbed well and quickly and concentrates in the brain and fatty tissues. It is classified as a Schedule II controlled substance.

The EMIT II Plus Phencyclidine Assay provides:

  • Detection of the analog 1-[1-(2-thienyl)-cyclohexyl]piperidine (TCP)
  • Excellent precision—all within-lab (total) CVs ≤0.6% or less across the assay range
  • Ready-to-use liquid reagents, calibrators, and controls
  • >99% correlation to reference method (GC/MS)

 

Applications are available for the Viva-Jr®, Viva-E®, Viva-ProE®, V-Twin® drug testing systems and AU® Series analyzers.

 

Technical Specifications

 Assay Principle

  Homogeneous Enzyme Multiplied Immonoassay (EMIT)

 Cut-off

  25 ng/mL

 Sample

  Urine

 Reagent Stability

  Unopened: until expiration date. Onboard instrument: up to 4 weeks

 Calibration Frequency

  As indicated by control results